載入...

Clinical Outcomes Observed among Biopsy Proven Lupus Nephritis Patients Treated with Mycophenolate Mofetil as First-line Therapy

Background and objective The rate of end-stage renal disease from lupus nephritis has not declined, in spite of recent advances in therapeutics, such as mycophenolate mofetil (MMF). To provide insight into rates of the clinical outcomes in current practice after biopsy-proven lupus nephritis, we use...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cureus
Main Authors: Timlin, Homa, Magder, Laurence, Petri, Michelle
格式: Artigo
語言:Inglês
出版: Cureus 2017
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5796813/
https://ncbi.nlm.nih.gov/pubmed/29410944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.1907
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!